Lung Cancer Clinical Trial

Long-Term Follow-Up Study of Patients Receiving ATL001

Summary

This is an Open-Label, Multi-Centre Phase II study to evaluate the long-term safety and clinical activity of ATL001, previously administered intravenously to patients in Study ATX-NS-001 (NCT04032847) or Study ATX-ME-001 (NCT03997474).

View Full Description

Full Description

Up to 90 patients with advanced non-small cell lung cancer ( NSCLC) or metastatic or recurrent melanoma will be enrolled after either: completing 2 years of follow-up visits in study ATX-NS-001 or study ATX-ME-001; or voluntary withdrawal from these studies prior to the completion of the 2 year of follow-up period.

Each patient will be followed up for a minimum period of 5 years, or until death if sooner, in this Long-Term Follow Up Protocol.

For patients who are still alive after 5 years of follow-up, survival data will continue to be collected until the end of the study, which will occur when the last patient has completed 5 years of follow-up withdraws from study or has died.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients must have given written informed consent to participate in the study.
Patients must have received ATL001 in a previous Clinical Trial.
Patients must be considered, in the opinion of the Investigator, capable of complying with the protocol requirements.

Exclusion Criteria:

There are no exclusion criteria.

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

1

Study ID:

NCT04785365

Recruitment Status:

Terminated

Sponsor:

Achilles Therapeutics UK Limited

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

University College London Hospital (UCLH) NHS Foundation Trust, University College Hospital
London , NW12P, United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Phase:

Phase 2

Estimated Enrollment:

1

Study ID:

NCT04785365

Recruitment Status:

Terminated

Sponsor:


Achilles Therapeutics UK Limited

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider